ABN Amro has secured its first lead manager role for GlaxoSmithKline alongside two of the UK pharmaceutical company's relationship banks on its debut euro-denominated benchmark bond.

The Dutch bank on Tuesday shared the books on GlaxoSmithKline's €1bn ($1.1bn) five-year bond with Credit Suisse First Boston (CSFB) and Royal Bank of Scotland (RBS). ABN Amro was ranked third among lead underwriters of investment grade corporate bonds in Europe, the Middle East and Africa in the first quarter of 2003 by Dealogic, the data provider.